| ★ | What is the Link Between Atopic Dermatitis and Asthma? With Eingun James Song, MD | | 40 | Estados Unidos | |
| 12 | Inhaled Treprostinil for IPF: TETON-1 Phase 3 Results With Steven Nathan, MD | ATS 2026 | | 301 | Estados Unidos | 65 |
| 3 | New Martin-Hopkins LDL-C-Estimating Equation Simplifies Implementation for Comparable Results | | 151 | Estados Unidos | 68 |
| 5 | Phase 3b Data on Ixekizumab, Tirzepatide for Psoriasis and Overweight, With Mark Lebwohl, MD | | 88 | Estados Unidos | 67 |
| 18 | Diagnosing Asthma in Kids Under 5 | GINA 2025 Criteria & ICS Decisions | | 84 | Estados Unidos | 64 |
| 13 | SUNRISE: Tezepelumab Shows Meaningful OCS Reduction in Severe Asthma | | 78 | Estados Unidos | 65 |
| 15 | Dupilumab Doubled Asthma Remission Odds in Type 2 Asthma: | | 71 | Estados Unidos | 65 |
| 16 | Tezepelumab Cuts Severe Asthma Exacerbations 70% in Real-World Patients | ATS 2026 | | 68 | Estados Unidos | 65 |
| 17 | Looking Beyond ALP Response in PBC With Saroglitazar, With Raj Vuppalanchi, MD | | 68 | Estados Unidos | 64 |
| 7 | Addressing Advances and Roadblocks in Lipid Management, With Joseph Saseen, PharmD | | 64 | Estados Unidos | 66 |
| 4 | Diagnosing Non-IgE Food Hypersensitivity | Brian Lacy, MD, PhD | EAC 2026 | | 31 | Estados Unidos | 67 |
| 20 | Increasing Guideline-Directed Care Adherence in Peripheral Artery Disease | | 31 | Estados Unidos | 64 |
| 8 | Addressing the Manifold Barriers in Hypertension, With Michael Miedema, MD | | 27 | Estados Unidos | 66 |
| 14 | What Are the Lasting Consequences of Childhood-Onset Atopic Dermatitis? | | 23 | Estados Unidos | 65 |
| 6 | Abdominal Pain and Bloating: Recognizing HAE, MCAS, and Eosinophilic GI Disorders | Brian Lacy, MD | | 20 | Estados Unidos | 66 |
| 19 | Are You Misdiagnosing Atopic Dermatitis? Matthew Zirwas, MD, on Adult-Onset AD | | 19 | Estados Unidos | 64 |
| 1 | Time to Minimum Residual C-Peptide As a Predictor of Treatment Efficacy in T1D | | 16 | Estados Unidos | 70 |
| 2 | What is the Role of Immunology in Atopic Dermatitis Care? With Jay Lieberman, MD | | 13 | Estados Unidos | 69 |
| 9 | How Should Clinicians Address the Link Between Atopic Dermatitis and Allergy? With Jay Lieberman, MD | | 13 | Estados Unidos | 66 |
| 11 | The Cost of Delay: How Prior Authorization Is Impacting Dermatology | | 12 | Estados Unidos | 65 |
| 10 | How Are Career and Education Opportunities Impacted by Atopic Dermatitis? | | 9 | Estados Unidos | 65 |